# Concord Biotech Ltd (CONCORDBIO)
> Exchange: NSE | Sector: Pharma | ISIN: INE338H01029

## Price
Current Price: ₹1,450.3
Day Change: -0.99%
52W High: ₹1704
52W Low: ₹987
Market Cap: ₹15,172 Cr

## About
Concord Biotech Ltd is a Pharma company listed on NSE.
Sector: Pharma

## Returns
1Y Return: 7.26%

## Valuation
P/E: 49.9
P/B: 7.5
EPS: ₹29.06
Book Value: ₹192.81
Dividend Yield: 0.5%

## Profitability
ROE: 13.5%

## Access
Current tier: anonymous
More history: Register free to see 5 more years.

## Data Freshness
Quote Updated: 2026-09-10T04:01:00.000Z
Price History Updated: 2026-09-10T18:56:37.017Z
Latest Price History Date: 2026-09-10
Technicals Updated: 2026-09-10T18:56:37.017Z
Quant Updated: 2026-09-10T18:56:37.017Z
Sentiment Updated: 2026-09-10T18:56:37.017Z
Financials Status: current
Financials Updated: 2026-09-07T18:27:12.640Z
Financials Last Attempt: 2026-09-11T18:34:13.799Z
Financials Provider Tried: yahoo
Latest P&L Period: FY26
Latest Balance Sheet Period: FY26
Latest Cash Flow Period: FY26

## P&L (TTM)
Revenue: ₹1108 Cr
Operating Profit: ₹388 Cr (OPM 35%)
Net Profit: ₹273 Cr
Tax: ₹91 Cr

## Annual P&L History
TTM: Rev ₹1108Cr | PAT ₹273Cr | OPM 35%
FY26: Rev ₹1055Cr | PAT ₹259Cr | OPM 35%
FY25: Rev ₹1200Cr | PAT ₹372Cr | OPM 42%

## Balance Sheet (FY26)
Total Assets: ₹2232 Cr
Total Liabilities: ₹2232 Cr
Borrowings: ₹2 Cr
Cash: —

## Shareholding
Promoters: 44.08%
FIIs: 7.53%
DIIs: 9.37%
Public: 39.04%

---
Source: rupiya.io/stocks/concordbio
Disclaimer: For research and education only. Not investment advice.